Bioharvest Sciences Stock Net Asset

CNVCF Stock  USD 6.15  0.03  0.49%   
Bioharvest Sciences fundamentals help investors to digest information that contributes to Bioharvest Sciences' financial success or failures. It also enables traders to predict the movement of Bioharvest OTC Stock. The fundamental analysis module provides a way to measure Bioharvest Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioharvest Sciences otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bioharvest Sciences OTC Stock Net Asset Analysis

Bioharvest Sciences' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current Bioharvest Sciences Net Asset

    
  10.21 M  
Most of Bioharvest Sciences' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioharvest Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Based on the recorded statements, Bioharvest Sciences has a Net Asset of 10.21 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net asset for all United States stocks is notably lower than that of the firm.

Bioharvest Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioharvest Sciences' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Bioharvest Sciences could also be used in its relative valuation, which is a method of valuing Bioharvest Sciences by comparing valuation metrics of similar companies.
Bioharvest Sciences is currently under evaluation in net asset category among its peers.

Bioharvest Fundamentals

About Bioharvest Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bioharvest Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioharvest Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioharvest Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Bioharvest OTC Stock

Bioharvest Sciences financial ratios help investors to determine whether Bioharvest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioharvest with respect to the benefits of owning Bioharvest Sciences security.